Michael Woudenberg - Dec 5, 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Chief Operating Officer
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg
Stock symbol
INM
Transactions as of
Dec 5, 2023
Transactions value $
$0
Form type
4
Date filed
12/6/2023, 09:02 AM
Previous filing
Dec 19, 2022
Next filing
Dec 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -848 -7.48% $0.00 10.5K Dec 5, 2023 Common shares 848 $270.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$367.125 using an exchange rate of C$1.3579 = $US1.00